Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours

Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours

(1) Background: Renal cell carcinoma (RCC) is a heterogeneous and complex disease with only partial response to therapy, high incidence of metastasis and recurrences, and scarce reliable biomarkers indicative of progression and survival. Cancer-associated fibroblasts (CAFs) play an important role su...

Full description

Bibliographic Details
Main Authors:	Jon Danel Solano-Iturri, Peio Errarte, María C. Etxezarraga, Enrique Echevarria, Javier Angulo, José I. López, Gorka Larrinaga
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	Cancers
Subjects:	clear cell renal cell carcinoma renal tumours prognosis FAP cancer associated fibroblast
Online Access:	https://www.mdpi.com/2072-6694/12/11/3393

Similar Items

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
by: Gorka Larrinaga, et al.
Published: (2021-02-01)

The effect of tranilast on fibroblast activation protein α (FAP-α) expression in normal and keloid fibroblasts in vitro
by: Paweł P. Antończak, et al.
Published: (2017-07-01)

Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours
by: Jon Danel Solano-Iturri, et al.
Published: (2021-02-01)

Selective Activity-Based Probes Targeting Fibroblast Activation Protein (FAP)
by: Johannes Vrijdag, et al.
Published: (2019-08-01)

Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
by: Paul Windisch, et al.
Published: (2021-02-01)

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel
by: Ana Sílvia Pires-Luís, et al.
Published: (2017-06-01)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
by: Ming Li, et al.
Published: (2020-12-01)

The presence of tumour‐infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma
by: Basile Tessier‐Cloutier, et al.
Published: (2021-07-01)

Collision Tumour of the Kidney: A Case Report
by: V Marisa D Souza, et al.
Published: (2021-01-01)

High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes
by: Mairene Coto-Llerena, et al.
Published: (2020-07-01)

CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity
by: Meng Q, et al.
Published: (2021-07-01)

Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation
by: Shalini Agnihotri, et al.
Published: (2014-01-01)

Preoperative anaemia and thrombocytosis predict adverse prognosis in non‐metastatic renal cell carcinoma with tumour thrombus
by: Ruotao Xiao, et al.
Published: (2021-02-01)

Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients
by: Manuel Röhrich, et al.
Published: (2020-08-01)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
by: Qiu Zhengqi, et al.
Published: (2021-01-01)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
by: Yi-Jun Xue, et al.
Published: (2019-08-01)

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
by: Jiang-hui Zeng, et al.
Published: (2019-08-01)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
by: Meng Q, et al.
Published: (2021-07-01)

Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma
by: Laura Lucarini, et al.
Published: (2018-01-01)

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored
by: Ju-Yoon Yoon, et al.
Published: (2020-04-01)

Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma
by: Nicholas H. Chakiryan, et al.
Published: (2021-07-01)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)

Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma
by: Gang Wang, et al.
Published: (2021-01-01)

Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances
by: Ren Juchao, et al.
Published: (2011-12-01)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
by: Emma Andersson Evelönn, et al.
Published: (2019-01-01)

Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma
by: Zhang GH, et al.
Published: (2018-09-01)

Analysis of Ferroptosis-Related Gene Expression and Prognostic Factors of Renal Clear Cell Carcinoma Based on TCGA Database
by: Ma S, et al.
Published: (2021-09-01)

Evaluation of the Relative Enhancement Ratio and Morphologic Findings on Biphasic CT to Differentiate Clear Cell and Non-Clear Cell Renal Cell Carcinoma
by: Nithida Na Songkhla
Published: (2016-06-01)

Evaluation of the Relative Enhancement Ratio and Morphologic Findings on Biphasic CT to Differentiate Clear Cell and Non-Clear Cell Renal Cell Carcinoma
by: Nithida Na Songkhla, et al.
Published: (2016-05-01)

High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
by: Min Li, et al.
Published: (2020-10-01)

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
by: Yongke You, et al.
Published: (2021-09-01)

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
by: Yicong Yao, et al.
Published: (2021-07-01)

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
by: Yicong Yao, et al.
Published: (2021-05-01)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
by: Yuanyuan Zhu, et al.
Published: (2021-07-01)

IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
by: Baozhong Yu, et al.
Published: (2021-02-01)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
by: Wen-Hao Xu, et al.
Published: (2019-11-01)

Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis
by: Mihyang Ha, et al.
Published: (2019-04-01)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
by: Jung Kwon Kim, et al.
Published: (2019-07-01)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
by: Yang Fu, et al.
Published: (2019-10-01)

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
by: Shen J, et al.
Published: (2019-06-01)